References

1. World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19 ; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf (accessed February 29, 2020).
2. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 48 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200308-sitrep-48-covid-19.pdf?sfvrsn=16f7ccef_4 (accessed March 8, 2020).
3. del Rio C, Malani PN. COVID-19—New Insights on a Rapidly Changing Epidemic. JAMA . 2020.
4. Read JM, Bridgen JR, Cummings DA, Ho A, Jewell CP. Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions. medRxiv . 2020.
5. Bauch CT, Lloyd-Smith JO, Coffee MP, Galvani AP. Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future. Epidemiology . 2005;16(6):791-801.
6. Park J-E, Jung S, Kim A, Park J-E. MERS transmission and risk factors: a systematic review. BMC Public Health . 2018;18(1):574.
7. Biggerstaff M, Cauchemez S, Reed C, Gambhir M, Finelli L. Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature. BMC Infectious Diseases . 2014;14(1):480.
8. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA . 2020.
9. Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerging Infectious Diseases . 2006;12(1):15-22.
10. World Health Organization. Cumulative Number of Reported Probable Cases of Severe Acute Respiratory Syndrome (SARS) 2020. Available from: http://www.who.int/csr/sars/country/en/ (accessed February 28, 2020).
11. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV) 2020. Available from: https://www.who.int/emergencies/mers-cov/en/ (accessed February 28, 2020).
12. Cetron M, Landwirth J. Public health and ethical considerations in planning for quarantine. The Yale journal of biology and medicine . 2005;78(5):329-34.
13. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. The Psychological Impact of Quarantine and How to Reduce It: Rapid Review of the Evidence. Available at SSRN 3532534 . 2020.
14. Jernigan DB. Update: Public Health Response to the Coronavirus Disease 2019 Outbreak — United States. MMWR - Morbidity & Mortality Weekly Report . 2020;69:216-9.
15. World Health Organization. Considerations for quarantine of individuals in the context of containment for coronavirus disease (COVID-19) ; 2020. Available from: https://www.who.int/internal-publications-detail/considerations-for-quarantine-of-individuals-in-the-context-of-containment-for-coronavirus-disease-(covid-19) (accessed February 29,2020).
16. Health WHODoM, Abuse S, Organization WH, Health WHODoM, Health SAM, Evidence WHOMH, et al. Mental health atlas 2005 . Geneva: World Health Organization; 2005. ISBN: 924156296X
17. Habibi R, Burci GL, de Campos TC, Chirwa D, Cinà M, Dagron S, et al. Do not violate the International Health Regulations during the COVID-19 outbreak. The Lancet . 2020;395(10225):664-6.
18. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement.Journal of Clinical Epidemiology . 2009;62(10):1006-12.
19. World Health Organization. Global research on coronavirus disease (COVID-19) . Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov (accessed February 12, 2020).
20. World Health Organization. Environmental health in emergencies. Available from: www.who.int/environmental_health_emergencies/disease_outbreaks/en/ (accessed February 25, 2020).
21. Veritas Health Innovation Melbourne Australia. Covidence systematic review software.
22. Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ . 2016;355:i4919.
23. Pitman R, Fisman D, Zaric GS, Postma M, Kretzschmar M, Edmunds J, et al. Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group–5. Medical Decision Making . 2012;32(5):712-21.
24. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical research ed) . 2008;336(7650):924-6.
25. Schünemann H, Brożek J, Guyatt G, Oxman A. GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013 2013. Available from: www.guidelinedevelopment.org/handbook (accessed February 25, 2020).
26. Pang X, Zhu Z, Xu F, Guo J, Gong X, Liu D, et al. Evaluation of control measures implemented in the severe acute respiratory syndrome outbreak in Beijing, 2003. JAMA . 2003;290(24):3215-21.
27. Park HC, Lee SH, Kim J, Kim DH, Cho A, Jeon HJ, et al. Effect of isolation practice on the transmission of middle east respiratory syndrome coronavirus among hemodialysis patients: A 2-year prospective cohort study. Medicine . 2020;99(3):e18782.
28. Wang TH, Wei KC, Hsiung CA, Maloney SA, Eidex RB, Posey DL, et al. Optimizing severe acute respiratory syndrome response strategies: lessons learned from quarantine. American Journal of Public Health . 2007;97 Suppl 1:S98-100.
29. Hsieh YH, King CC, Chen CW, Ho MS, Lee JY, Liu FC, et al. Quarantine for SARS, Taiwan. Emerging Infectious Diseases . 2005;11(2):278-82.
30. Becker NG, Glass K, Li Z, Aldis GK. Controlling emerging infectious diseases like SARS. Mathematical Biosciences . 2005;193(2):205-21.
31. Chau PH, Yip PS. Monitoring the severe acute respiratory syndrome epidemic and assessing effectiveness of interventions in Hong Kong Special Administrative Region. Journal of Epidemiology & Community Health . 2003;57(10):766-9.
32. Day T, Park A, Madras N, Gumel A, Wu J. When is quarantine a useful control strategy for emerging infectious diseases? American Journal of Epidemiology . 2006;163(5):479-85.
33. Fraser C, Riley S, Anderson RM, Ferguson NM. Factors that make an infectious disease outbreak controllable. Proceedings of the National Academy of Sciences of the United States of America . 2004;101(16):6146-51.
34. Gumel AB, Ruan S, Day T, Watmough J, Brauer F, van den Driessche P, et al. Modelling strategies for controlling SARS outbreaks.Proceedings of the Royal Society of London - Series B: Biological Sciences . 2004;271(1554):2223-32.
35. Gupta AG, Moyer CA, Stern DT. The economic impact of quarantine: SARS in Toronto as a case study. Journal of Infection . 2005;50(5):386-93.
36. Hsieh YH, King CC, Chen CW, Ho MS, Hsu SB, Wu YC. Impact of quarantine on the 2003 SARS outbreak: a retrospective modeling study.Journal of Theoretical Biology . 2007;244(4):729-36.
37. Lloyd-Smith JO, Galvani AP, Getz WM. Curtailing transmission of severe acute respiratory syndrome within a community and its hospital.Proceedings of the Royal Society of London - Series B: Biological Sciences . 2003;270(1528):1979-89.
38. Mubayi A, Zaleta CK, Martcheva M, Castillo-Chavez C. A cost-based comparison of quarantine strategies for new emerging diseases.Mathematical Biosciences & Engineering: MBE . 2010;7(3):687-717.
39. Nishiura H, Patanarapelert K, Sriprom M, Sarakorn W, Sriyab S, Ming Tang I. Modelling potential responses to severe acute respiratory syndrome in Japan: the role of initial attack size, precaution, and quarantine. Journal of Epidemiology & Community Health . 2004;58(3):186-91.
40. Peak CM, Childs LM, Grad YH, Buckee CO. Comparing nonpharmaceutical interventions for containing emerging epidemics. Proceedings of the National Academy of Sciences of the United States of America . 2017;114(15):4023-8.
41. Pourbohloul B, Meyers LA, Skowronski DM, Krajden M, Patrick DM, Brunham RC. Modeling control strategies of respiratory pathogens.Emerging Infectious Diseases . 2005;11(8):1249-56.
42. Wang W, Ruan S. Simulating the SARS outbreak in Beijing with limited data. Journal of Theoretical Biology . 2004;227(3):369-79.
43. Yip PS, Hsieh YH, Xu Y, Lam KF, King CC, Chang HL. Assessment of intervention measures for the 2003 SARS epidemic in Taiwan by use of a back-projection method. Infection Control & Hospital Epidemiology . 2007;28(5):525-30.
44. Zhang XS, Pebody R, Charlett A, de Angelis D, Birrell P, Kang H, et al. Estimating and modelling the transmissibility of Middle East Respiratory Syndrome CoronaVirus during the 2015 outbreak in the Republic of Korea. Influenza & Other Respiratory Viruses . 2017;11(5):434-44.
45. Wen-Tao WU D-NL, Li LI, et al. Analysis of the role of different intensity prevention and control measures in the current epidemic of novel coronavirus (2019-nCoV) infected pneumonia in Wuhan based on SIR model. New Medicine . 2020;30(1):78-82.
46. Yue Y, Yue C, Keji L, Xinyue L, Boxi X, Yu J, et al. Modeling and Prediction of New Coronavirus Pneumonia Based Time-delay Dynamic System.Scientia Sinica Maathematica . 2020.
47. Jefferson T, Del Mar CB, Dooley L, Ferroni E, Al-Ansary LA, Bawazeer GA, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database of Systematic Reviews . 2011(7):CD006207.
48. Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. International Journal of Infectious Diseases . 2020.
49. Zhou T LQ, Yang ZM, et al. . Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019-nCoV[J].Chinese Journal of Evidence-based Medicine (preprint) . 2020;20(3):1-6.
50. Gartlehner G, Affengruber L, Titscher V, Noel-Storr A, Dooley G, Ballarini N, et al. Single-reviewer abstract screening missed 13 percent of relevant studies: a crowd-based, randomized controlled trial.Journal of Clinical Epidemiology . 2020.